Bolt Biotherapeutics (BOLT) Asset Utilization Ratio (2021 - 2025)
Bolt Biotherapeutics (BOLT) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.13 as the latest value for Q4 2025.
- Quarterly Asset Utilization Ratio rose 71.68% to 0.13 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13 through Dec 2025, up 71.68% year-over-year, with the annual reading at 0.1 for FY2025, 66.0% up from the prior year.
- Asset Utilization Ratio hit 0.13 in Q4 2025 for Bolt Biotherapeutics, up from 0.07 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.13 in Q4 2025 to a low of 0.0 in Q1 2021.
- Historically, Asset Utilization Ratio has averaged 0.04 across 5 years, with a median of 0.04 in 2025.
- Biggest five-year swings in Asset Utilization Ratio: soared 1844.82% in 2022 and later tumbled 47.58% in 2025.
- Year by year, Asset Utilization Ratio stood at 0.0 in 2021, then surged by 516.03% to 0.02 in 2022, then surged by 94.16% to 0.05 in 2023, then surged by 56.59% to 0.07 in 2024, then skyrocketed by 71.68% to 0.13 in 2025.
- Business Quant data shows Asset Utilization Ratio for BOLT at 0.13 in Q4 2025, 0.07 in Q3 2025, and 0.05 in Q2 2025.